*  Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of...
Karnofsky performance status > 60 (ECOG 0-2). - Prior treatment with an EGFR Inhibitor is allowed if it was a part of prior ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Squamous Cell Carcinoma of the Head and Neck ...
http://www.knowcancer.com/cancer-trials/NCT01104922/
*  Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Karnofsky performance status >= 60%. - Absolute neutrophil count (ANC) >= 1.5 x 10^9/L. - Platelets >= 100 x 10^9/L. - ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult ...
http://www.knowcancer.com/cancer-trials/NCT01753713/
*  Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia
Karnofsky performance status >= 60%. - Total bilirubin < 1.5 x institutional upper limit of normal. - Aspartate ... Enrollment Status:. Not Enrolling. Gender:. Both. Conditions:. Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, ...
http://www.knowcancer.com/cancer-trials/NCT01876953/
*  Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small...
Performance Status Karnofsky > than or equal to 70%. - Peripheral neuropathy must be < than grade 1. - Hematologic (minimal ... Performance status 70% on the Karnofsky scale.. - Congestive heart failure with New York Heart Association functional ... Patients must be at least 2 weeks status post complete (R0) surgical resection of. pathologically-proven NSCLC (stage IA-IIIB ...
http://www.knowcancer.com/cancer-trials/NCT00675597/
*  Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
ECOG performance status >=2 (Karnofsky >=60%). Patients with PS of 3 are eligible if. their PS is due to pain, which would ...
http://www.knowcancer.com/cancer-trials/NCT01042704/
*  Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With...
Karnofsky performance status > 50%. - written informed consent to participate. - erythropoietin level > 200 mU/ml or failure of ...
http://www.knowcancer.com/cancer-trials/NCT00977132/
*  Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Performance Status: Karnofsky > or = 50 (>10 years of age) and Lansky > or = 50 for. patients < or = 10 years of age. Prior ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary ...
http://www.knowcancer.com/cancer-trials/NCT00975819/
*  Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion
Karnofsky Performance Status > 70;. - Written informed patient consent were obtained.. Exclusion Criteria:. - Hemorrhagic ...
http://www.knowcancer.com/cancer-trials/NCT00789087/
*  Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and...
Karnofsky performance status >= 70%. - Normal marrow function: leukocytes >= 3,000/µl; absolute neutrophil count ≥ 1,500µl;. ... Enrollment Status:. Not Enrolling. Gender:. Both. Conditions:. Carcinoma, Non-Small-Cell Lung ...
http://www.knowcancer.com/cancer-trials/NCT00130780/
*  177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Karnofsky Performance Status - Life expectancy - History of deep vein thrombosis and/or pulmonary embolus within 3 months of ...
http://www.knowcancer.com/cancer-trials/NCT00859781/
*  Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer
Karnofsky performance status > 70.. - FEV1 sufficient for patients to tolerate radiation therapy which is at the discretion. of ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Carcinoma, Non-Small-Cell Lung ...
http://www.knowcancer.com/cancer-trials/NCT00178256/
*  HAI Via Interventionally Implanted Port Catheter Systems
Karnofsky performance status => 70%, or ECOG status 0-2. - >18 years of age. - life expectancy > 6 months. - compliance of the ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Colorectal Cancer, Liver Neoplasms, Hepatocellular Carcinoma ...
http://www.knowcancer.com/cancer-trials/NCT00356161/
*  Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
Karnofsky performance status >= 80. - No prior treatment for dysplasia in the past 4 months. Exclusion Criteria:. - ...
http://www.knowcancer.com/cancer-trials/NCT00212381/
*  Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
Karnofsky performance status > 60 %. Exclusion Criteria:. - Oral treatment is not feasible. - Severe hepatic impairment Child- ...
http://www.knowcancer.com/cancer-trials/NCT00373815/
*  Ketoconazole and Dexamethasone in Prostate Cancer
Karnofsky Performance Status ≥ 60%.. - Patients receiving any other hormonal therapy, including any dose of megestrol. acetate ...
http://www.knowcancer.com/cancer-trials/NCT01036594/
*  Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Performance status: Karnofsky ≥ 70%., or Lansky≥70% Consent: All patients must sign. informed consent. Exclusion Criteria:. - ...
http://www.knowcancer.com/cancer-trials/NCT01457885/
*  Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease
Karnofsky Performance Status ≥70%.. - Life expectancy of >2 months.. - Granulocyte count ≥1,000/mm3 and a platelet count ≥ ...
http://www.knowcancer.com/cancer-trials/NCT00123942/
*  Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma
Karnofsky performance status of > 60%. - ANC >= 1000/uL. - Plts >= 50,000/uL. - Total bilirubin within 1.5 x of the upper limit ... Voluntary written informed consent before performance of any study-related procedure. not part of normal medical care, with the ...
http://www.knowcancer.com/cancer-trials/NCT01393717/
*  Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Karnofsky Performance Status (KPS) >=70%. - Histologic evidence of multiple myeloma, measurable relapsed or relapsed/refractory ...
http://www.knowcancer.com/cancer-trials/NCT00461045/
*  Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer
Karnofsky performance status ≥ 80.. - Adequate organ function:. - AST and ALT ≤ 2.0 x upper limit of normal (ULN); total serum ... Any other major illness or peripheral blood vein status that, in the investigator's. judgement, will substantially increase the ...
http://www.knowcancer.com/cancer-trials/NCT00859729/
*  Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed...
Karnofsky performance status ≥ 60%. - Absolute neutrophil count ≥ 1500/mm^3. - Platelet count ≥ 100,000/mm^3. - Bilirubin ≤ 1.5 ... Enrollment Status:. Not Enrolling. Gender:. Both. Conditions:. Brain and Central Nervous System Tumors ...
http://www.knowcancer.com/cancer-trials/NCT00262730/
*  Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
Karnofsky performance status (KPS) >= 60, Eastern Cooperative Oncology Group (ECOG). performance status =< 2. - Creatinine ... Enrollment Status:. Open (Enrolling). Gender:. Both. Conditions:. Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute ...
http://www.knowcancer.com/cancer-trials/NCT01414127/
*  A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Karnofsky performance Status ≥ 70%. - Male or female patients of child-producing potential must agree to use contraception. or ...
http://www.knowcancer.com/cancer-trials/NCT01776307/
*  Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver
Karnofsky performance status ≥ 70%. - Not pregnant or nursing. - Negative pregnancy test. - Fertile patients must use effective ... Hormone-receptor status not specified. PATIENT CHARACTERISTICS:. - Female. - Menopausal status not specified. - Granulocyte ...
http://www.knowcancer.com/cancer-trials/NCT00301106/
*  Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX
Karnofsky Performance Status >70. - Laboratory criteria: Absolute neutrophil count > 1.5 K; Platelets > 100 K; Total. Bilirubin ... Hepatitis B (HBsAg+) or C (anti-HCV Ab+) carrier status (anti-viral agents allowed if. clinically needed). - Informed consent ...
http://www.knowcancer.com/cancer-trials/NCT01395667/